EP2024512A4 - METHODS FOR THE DIAGNOSIS OF ABNORMAL F CHARACTERS - Google Patents

METHODS FOR THE DIAGNOSIS OF ABNORMAL F CHARACTERS

Info

Publication number
EP2024512A4
EP2024512A4 EP07784442A EP07784442A EP2024512A4 EP 2024512 A4 EP2024512 A4 EP 2024512A4 EP 07784442 A EP07784442 A EP 07784442A EP 07784442 A EP07784442 A EP 07784442A EP 2024512 A4 EP2024512 A4 EP 2024512A4
Authority
EP
European Patent Office
Prior art keywords
diagnosis
characters
abnormal
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07784442A
Other languages
German (de)
French (fr)
Other versions
EP2024512A2 (en
Inventor
Ravi Kapur
Mehmet Toner
Zihua Wang
Martin Fuchs
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Cellective DX Corp
Verinata Health Inc
Original Assignee
General Hospital Corp
Cellective DX Corp
Artemis Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp, Cellective DX Corp, Artemis Health Inc filed Critical General Hospital Corp
Priority to EP11159371.1A priority Critical patent/EP2366801B1/en
Priority to EP12175907A priority patent/EP2548972A1/en
Priority to EP18167847.5A priority patent/EP3406736B1/en
Priority to EP22194250.1A priority patent/EP4170042A1/en
Publication of EP2024512A2 publication Critical patent/EP2024512A2/en
Publication of EP2024512A4 publication Critical patent/EP2024512A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/16Primer sets for multiplex assays
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10Investigating individual particles
    • G01N2015/1006Investigating individual particles for cytology
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10Investigating individual particles
    • G01N2015/1029Particle size

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EP07784442A 2006-06-14 2007-06-14 METHODS FOR THE DIAGNOSIS OF ABNORMAL F CHARACTERS Withdrawn EP2024512A4 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP11159371.1A EP2366801B1 (en) 2006-06-14 2007-06-14 Methods for the diagnosis of fetal abnormalities
EP12175907A EP2548972A1 (en) 2006-06-14 2007-06-14 Methods for the diagnosis of fetal abnormalities
EP18167847.5A EP3406736B1 (en) 2006-06-14 2007-06-14 Methods for the diagnosis of fetal abnormalities
EP22194250.1A EP4170042A1 (en) 2006-06-14 2007-06-14 Methods for the diagnosis of fetal abnormalities

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80481706P 2006-06-14 2006-06-14
US82077806P 2006-07-28 2006-07-28
PCT/US2007/071250 WO2007147076A2 (en) 2006-06-14 2007-06-14 Methods for the diagnosis of fetal abnormalities

Related Child Applications (3)

Application Number Title Priority Date Filing Date
EP18167847.5A Division EP3406736B1 (en) 2006-06-14 2007-06-14 Methods for the diagnosis of fetal abnormalities
EP11159371.1A Division EP2366801B1 (en) 2006-06-14 2007-06-14 Methods for the diagnosis of fetal abnormalities
EP22194250.1A Division EP4170042A1 (en) 2006-06-14 2007-06-14 Methods for the diagnosis of fetal abnormalities

Publications (2)

Publication Number Publication Date
EP2024512A2 EP2024512A2 (en) 2009-02-18
EP2024512A4 true EP2024512A4 (en) 2009-12-09

Family

ID=38832875

Family Applications (5)

Application Number Title Priority Date Filing Date
EP22194250.1A Pending EP4170042A1 (en) 2006-06-14 2007-06-14 Methods for the diagnosis of fetal abnormalities
EP18167847.5A Active EP3406736B1 (en) 2006-06-14 2007-06-14 Methods for the diagnosis of fetal abnormalities
EP07784442A Withdrawn EP2024512A4 (en) 2006-06-14 2007-06-14 METHODS FOR THE DIAGNOSIS OF ABNORMAL F CHARACTERS
EP12175907A Withdrawn EP2548972A1 (en) 2006-06-14 2007-06-14 Methods for the diagnosis of fetal abnormalities
EP11159371.1A Active EP2366801B1 (en) 2006-06-14 2007-06-14 Methods for the diagnosis of fetal abnormalities

Family Applications Before (2)

Application Number Title Priority Date Filing Date
EP22194250.1A Pending EP4170042A1 (en) 2006-06-14 2007-06-14 Methods for the diagnosis of fetal abnormalities
EP18167847.5A Active EP3406736B1 (en) 2006-06-14 2007-06-14 Methods for the diagnosis of fetal abnormalities

Family Applications After (2)

Application Number Title Priority Date Filing Date
EP12175907A Withdrawn EP2548972A1 (en) 2006-06-14 2007-06-14 Methods for the diagnosis of fetal abnormalities
EP11159371.1A Active EP2366801B1 (en) 2006-06-14 2007-06-14 Methods for the diagnosis of fetal abnormalities

Country Status (2)

Country Link
EP (5) EP4170042A1 (en)
WO (1) WO2007147076A2 (en)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITBO20050481A1 (en) 2005-07-19 2007-01-20 Silicon Biosystems S R L METHOD AND APPARATUS FOR THE HANDLING AND / OR IDENTIFICATION OF PARTICLES
US9424392B2 (en) 2005-11-26 2016-08-23 Natera, Inc. System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals
US11111544B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US10081839B2 (en) * 2005-07-29 2018-09-25 Natera, Inc System and method for cleaning noisy genetic data and determining chromosome copy number
US11111543B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
ITBO20050646A1 (en) 2005-10-26 2007-04-27 Silicon Biosystem S R L METHOD AND APPARATUS FOR CHARACTERIZATION AND COUNTING OF PARTICLES
ITTO20060226A1 (en) 2006-03-27 2007-09-28 Silicon Biosystem S P A METHOD AND APPARATUS FOR PROCESSING AND OR ANALYSIS AND OR SELECTION OF PARTICLES, IN PARTICULAR BIOLOGICAL PARTICLES
EP2029779A4 (en) 2006-06-14 2010-01-20 Living Microsystems Inc Use of highly parallel snp genotyping for fetal diagnosis
WO2009035447A1 (en) * 2006-06-14 2009-03-19 Living Microsystems, Inc. Diagnosis of fetal abnormalities by comparative genomic hybridization analysis
US20080050739A1 (en) 2006-06-14 2008-02-28 Roland Stoughton Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
PL2557520T3 (en) 2007-07-23 2021-10-11 The Chinese University Of Hong Kong Determining a nucleic acid sequence imbalance
US12180549B2 (en) 2007-07-23 2024-12-31 The Chinese University Of Hong Kong Diagnosing fetal chromosomal aneuploidy using genomic sequencing
ITTO20070771A1 (en) 2007-10-29 2009-04-30 Silicon Biosystems Spa METHOD AND APPARATUS FOR IDENTIFICATION AND HANDLING OF PARTICLES
US10895575B2 (en) 2008-11-04 2021-01-19 Menarini Silicon Biosystems S.P.A. Method for identification, selection and analysis of tumour cells
IT1391619B1 (en) * 2008-11-04 2012-01-11 Silicon Biosystems Spa METHOD FOR THE IDENTIFICATION, SELECTION AND ANALYSIS OF TUMOR CELLS
JP5834001B2 (en) 2009-03-17 2015-12-16 シリコン・バイオシステムズ・ソシエタ・ペル・アチオニ Microfluidic device for separating cells
WO2010121294A1 (en) 2009-04-21 2010-10-28 Genetic Technologies Limited Methods for obtaining fetal genetic material
WO2011041485A1 (en) 2009-09-30 2011-04-07 Gene Security Network, Inc. Methods for non-invasive prenatal ploidy calling
CA2817990A1 (en) 2009-12-23 2011-06-30 Genetic Technologies Limited Methods of enriching and detecting fetal nucleic acids
US20110312503A1 (en) 2010-01-23 2011-12-22 Artemis Health, Inc. Methods of fetal abnormality detection
US11939634B2 (en) 2010-05-18 2024-03-26 Natera, Inc. Methods for simultaneous amplification of target loci
US12545960B2 (en) 2010-05-18 2026-02-10 Natera, Inc. Methods for simultaneous amplification of target loci
US11322224B2 (en) 2010-05-18 2022-05-03 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11326208B2 (en) 2010-05-18 2022-05-10 Natera, Inc. Methods for nested PCR amplification of cell-free DNA
US20190010543A1 (en) 2010-05-18 2019-01-10 Natera, Inc. Methods for simultaneous amplification of target loci
US11339429B2 (en) 2010-05-18 2022-05-24 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US10316362B2 (en) 2010-05-18 2019-06-11 Natera, Inc. Methods for simultaneous amplification of target loci
US11408031B2 (en) 2010-05-18 2022-08-09 Natera, Inc. Methods for non-invasive prenatal paternity testing
US12152275B2 (en) 2010-05-18 2024-11-26 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11332793B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for simultaneous amplification of target loci
WO2011146632A1 (en) 2010-05-18 2011-11-24 Gene Security Network Inc. Methods for non-invasive prenatal ploidy calling
US9677118B2 (en) 2014-04-21 2017-06-13 Natera, Inc. Methods for simultaneous amplification of target loci
US12221653B2 (en) 2010-05-18 2025-02-11 Natera, Inc. Methods for simultaneous amplification of target loci
US11332785B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for non-invasive prenatal ploidy calling
IT1403518B1 (en) 2010-12-22 2013-10-31 Silicon Biosystems Spa MICROFLUID DEVICE FOR PARTICLE HANDLING
CN103608466B (en) 2010-12-22 2020-09-18 纳特拉公司 Non-invasive prenatal paternity testing method
RU2671980C2 (en) 2011-02-09 2018-11-08 Натера, Инк. Methods for non-invasive prenatal ploidy calling
AU2012214312A1 (en) 2011-02-09 2013-08-22 Bio-Rad Laboratories, Inc. Analysis of nucleic acids
ITTO20110990A1 (en) 2011-10-28 2013-04-29 Silicon Biosystems Spa METHOD AND APPARATUS FOR OPTICAL ANALYSIS OF LOW TEMPERATURE PARTICLES
ITBO20110766A1 (en) 2011-12-28 2013-06-29 Silicon Biosystems Spa DEVICES, EQUIPMENT, KITS AND METHOD FOR THE TREATMENT OF A BIOLOGICAL SAMPLE
US20140100126A1 (en) 2012-08-17 2014-04-10 Natera, Inc. Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data
WO2014078739A1 (en) * 2012-11-15 2014-05-22 The General Hospital Corporation Methods and systems for diagnosing prenatal abnormalities
US20150064153A1 (en) 2013-03-15 2015-03-05 The Trustees Of Princeton University High efficiency microfluidic purification of stem cells to improve transplants
US12590955B2 (en) 2013-03-15 2026-03-31 Zeon Corporation Methods and systems for processing particles
EP3608022A1 (en) 2013-03-15 2020-02-12 The Trustees of Princeton University Methods and devices for high throughput purification
US11493428B2 (en) 2013-03-15 2022-11-08 Gpb Scientific, Inc. On-chip microfluidic processing of particles
US10577655B2 (en) 2013-09-27 2020-03-03 Natera, Inc. Cell free DNA diagnostic testing standards
US10262755B2 (en) 2014-04-21 2019-04-16 Natera, Inc. Detecting cancer mutations and aneuploidy in chromosomal segments
CA2945962C (en) 2014-04-21 2023-08-29 Natera, Inc. Detecting mutations and ploidy in chromosomal segments
US12492429B2 (en) 2014-04-21 2025-12-09 Natera, Inc. Detecting mutations and ploidy in chromosomal segments
US20180173846A1 (en) 2014-06-05 2018-06-21 Natera, Inc. Systems and Methods for Detection of Aneuploidy
US10364467B2 (en) 2015-01-13 2019-07-30 The Chinese University Of Hong Kong Using size and number aberrations in plasma DNA for detecting cancer
US11479812B2 (en) 2015-05-11 2022-10-25 Natera, Inc. Methods and compositions for determining ploidy
WO2017020023A2 (en) * 2015-07-29 2017-02-02 Progenity, Inc. Nucleic acids and methods for detecting chromosomal abnormalities
CN108473955B (en) * 2016-02-03 2022-02-01 深圳华大生命科学研究院 Method for separating target cells from blood sample and application thereof
RU2760913C2 (en) 2016-04-15 2021-12-01 Натера, Инк. Methods for identifying lung cancer
WO2018067517A1 (en) 2016-10-04 2018-04-12 Natera, Inc. Methods for characterizing copy number variation using proximity-litigation sequencing
GB201618485D0 (en) 2016-11-02 2016-12-14 Ucl Business Plc Method of detecting tumour recurrence
US10011870B2 (en) 2016-12-07 2018-07-03 Natera, Inc. Compositions and methods for identifying nucleic acid molecules
WO2018156418A1 (en) 2017-02-21 2018-08-30 Natera, Inc. Compositions, methods, and kits for isolating nucleic acids
US12084720B2 (en) 2017-12-14 2024-09-10 Natera, Inc. Assessing graft suitability for transplantation
US12398389B2 (en) 2018-02-15 2025-08-26 Natera, Inc. Methods for isolating nucleic acids with size selection
CN108118094A (en) * 2018-03-06 2018-06-05 杨祚璋 Bone and flesh tumor metastasis Research of predicting markers ENSG00000267886 and its application
US12024738B2 (en) 2018-04-14 2024-07-02 Natera, Inc. Methods for cancer detection and monitoring
US12234509B2 (en) 2018-07-03 2025-02-25 Natera, Inc. Methods for detection of donor-derived cell-free DNA
EP3947718A4 (en) 2019-04-02 2022-12-21 Enumera Molecular, Inc. METHODS, SYSTEMS AND COMPOSITIONS FOR COUNTING NUCLEIC ACID MOLECULES
US12305235B2 (en) 2019-06-06 2025-05-20 Natera, Inc. Methods for detecting immune cell DNA and monitoring immune system
WO2021097307A1 (en) * 2019-11-14 2021-05-20 Bio-Rad Laboratories, Inc. Partition-based determination of target copy number for single cells by non-endpoint amplification

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999022868A1 (en) * 1997-10-31 1999-05-14 Bbi Bioseq, Inc. Pressure-enhanced extraction and purification
WO2000040750A1 (en) * 1998-12-30 2000-07-13 Gyros Ab Method for sequencing dna using a microfluidic device
US20030165852A1 (en) * 2000-11-15 2003-09-04 Schueler Paula A. Methods and reagents for identifying rare fetal cells in the maternal circulation
WO2004029221A2 (en) * 2002-09-27 2004-04-08 The General Hospital Corporation Microfluidic device for cell separation and uses thereof

Family Cites Families (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242794A (en) 1984-12-13 1993-09-07 Applied Biosystems, Inc. Detection of specific sequences in nucleic acids
JPH0610416B2 (en) 1987-12-28 1994-02-09 いすゞ自動車株式会社 Controller for turbocharger with rotating electric machine
GB8810400D0 (en) 1988-05-03 1988-06-08 Southern E Analysing polynucleotide sequences
US4988617A (en) 1988-03-25 1991-01-29 California Institute Of Technology Method of detecting a nucleotide change in nucleic acids
US5700637A (en) 1988-05-03 1997-12-23 Isis Innovation Limited Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays
US6054270A (en) 1988-05-03 2000-04-25 Oxford Gene Technology Limited Analying polynucleotide sequences
US5744101A (en) 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US5800992A (en) 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US5424186A (en) 1989-06-07 1995-06-13 Affymax Technologies N.V. Very large scale immobilized polymer synthesis
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US6346413B1 (en) 1989-06-07 2002-02-12 Affymetrix, Inc. Polymer arrays
US5302509A (en) * 1989-08-14 1994-04-12 Beckman Instruments, Inc. Method for sequencing polynucleotides
US5641628A (en) * 1989-11-13 1997-06-24 Children's Medical Center Corporation Non-invasive method for isolation and detection of fetal DNA
US5494810A (en) 1990-05-03 1996-02-27 Cornell Research Foundation, Inc. Thermostable ligase-mediated DNA amplifications system for the detection of genetic disease
US5427663A (en) 1993-06-08 1995-06-27 British Technology Group Usa Inc. Microlithographic array for macromolecule and cell fractionation
US6287850B1 (en) 1995-06-07 2001-09-11 Affymetrix, Inc. Bioarray chip reaction apparatus and its manufacture
DE69527585T2 (en) 1994-06-08 2003-04-03 Affymetrix, Inc. Method and device for packaging chips
US5733729A (en) 1995-09-14 1998-03-31 Affymetrix, Inc. Computer-aided probability base calling for arrays of nucleic acid probes on chips
US5799637A (en) 1996-05-01 1998-09-01 Cifuni; Charles G. Rocket effect sparking plug
US6969488B2 (en) 1998-05-22 2005-11-29 Solexa, Inc. System and apparatus for sequential processing of analytes
EP1090293B2 (en) 1998-06-24 2019-01-23 Illumina, Inc. Decoding of array sensors with microspheres
US20040106110A1 (en) 1998-07-30 2004-06-03 Solexa, Ltd. Preparation of polynucleotide arrays
US20030022207A1 (en) 1998-10-16 2003-01-30 Solexa, Ltd. Arrayed polynucleotides and their use in genome analysis
US6787308B2 (en) 1998-07-30 2004-09-07 Solexa Ltd. Arrayed biomolecules and their use in sequencing
US7510841B2 (en) 1998-12-28 2009-03-31 Illumina, Inc. Methods of making and using composite arrays for the detection of a plurality of target analytes
US6429027B1 (en) 1998-12-28 2002-08-06 Illumina, Inc. Composite arrays utilizing microspheres
US6846460B1 (en) 1999-01-29 2005-01-25 Illumina, Inc. Apparatus and method for separation of liquid phases of different density and for fluorous phase organic syntheses
ATE556149T1 (en) * 1999-02-23 2012-05-15 Caliper Life Sciences Inc MANIPULATION OF MICROPARTICLES IN MICROFLUIDIC SYSTEMS
US6355431B1 (en) 1999-04-20 2002-03-12 Illumina, Inc. Detection of nucleic acid amplification reactions using bead arrays
US20050244870A1 (en) 1999-04-20 2005-11-03 Illumina, Inc. Nucleic acid sequencing using microsphere arrays
US7056661B2 (en) 1999-05-19 2006-06-06 Cornell Research Foundation, Inc. Method for sequencing nucleic acid molecules
EP1190100B1 (en) 1999-05-20 2012-07-25 Illumina, Inc. Combinatorial decoding of random nucleic acid arrays
US6544732B1 (en) 1999-05-20 2003-04-08 Illumina, Inc. Encoding and decoding of array sensors utilizing nanocrystals
AU779835B2 (en) 1999-05-20 2005-02-10 Illumina, Inc. Method and apparatus for retaining and presenting at least one microsphere array to solutions and/or to optical imaging systems
WO2001018524A2 (en) 1999-08-30 2001-03-15 Illumina, Inc. Methods for improving signal detection from an array
US7211390B2 (en) 1999-09-16 2007-05-01 454 Life Sciences Corporation Method of sequencing a nucleic acid
US7244559B2 (en) 1999-09-16 2007-07-17 454 Life Sciences Corporation Method of sequencing a nucleic acid
US6505125B1 (en) 1999-09-28 2003-01-07 Affymetrix, Inc. Methods and computer software products for multiple probe gene expression analysis
AU7537200A (en) 1999-09-29 2001-04-30 Solexa Ltd. Polynucleotide sequencing
US6692952B1 (en) 1999-11-10 2004-02-17 Massachusetts Institute Of Technology Cell analysis and sorting apparatus for manipulation of cells
CA2394374A1 (en) 1999-12-13 2001-06-14 Illumina, Inc. Oligonucleotide synthesizer
US6582938B1 (en) 2001-05-11 2003-06-24 Affymetrix, Inc. Amplification of nucleic acids
GB0002389D0 (en) 2000-02-02 2000-03-22 Solexa Ltd Molecular arrays
US6913884B2 (en) 2001-08-16 2005-07-05 Illumina, Inc. Compositions and methods for repetitive use of genomic DNA
DK1259643T3 (en) 2000-02-07 2009-02-23 Illumina Inc Method for Detecting Nucleic Acid Using Universal Priming
WO2001057268A2 (en) 2000-02-07 2001-08-09 Illumina, Inc. Nucleic acid detection methods using universal priming
US6770441B2 (en) 2000-02-10 2004-08-03 Illumina, Inc. Array compositions and methods of making same
GB0016742D0 (en) * 2000-07-10 2000-08-30 Simeg Limited Diagnostic method
US6897023B2 (en) 2000-09-27 2005-05-24 The Molecular Sciences Institute, Inc. Method for determining relative abundance of nucleic acid sequences
DE60131903T2 (en) 2000-10-24 2008-11-27 The Board of Trustees of the Leland S. Stanford Junior University, Palo Alto DIRECT MULTIPLEX CHARACTERIZATION OF GENOMIC DNA
US7078168B2 (en) * 2001-02-27 2006-07-18 Biotage Ab Method for determining allele frequencies
DE10120797B4 (en) 2001-04-27 2005-12-22 Genovoxx Gmbh Method for analyzing nucleic acid chains
FR2824144B1 (en) * 2001-04-30 2004-09-17 Metagenex S A R L METHOD OF PRENATAL DIAGNOSIS ON FETAL CELLS ISOLATED FROM MATERNAL BLOOD
AU2002337030A1 (en) 2001-08-29 2003-03-18 Genovoxx Gmbh Method for analyzing nucleic acid sequences and gene expression
DE10246005A1 (en) 2001-10-04 2003-04-30 Genovoxx Gmbh Automated nucleic acid sequencer, useful e.g. for analyzing gene expression, based on parallel incorporation of fluorescently labeled terminating nucleotides
DE10149786B4 (en) 2001-10-09 2013-04-25 Dmitry Cherkasov Surface for studies of populations of single molecules
US6956114B2 (en) 2001-10-30 2005-10-18 '454 Corporation Sulfurylase-luciferase fusion proteins and thermostable sulfurylase
US6902921B2 (en) 2001-10-30 2005-06-07 454 Corporation Sulfurylase-luciferase fusion proteins and thermostable sulfurylase
US20050124022A1 (en) 2001-10-30 2005-06-09 Maithreyan Srinivasan Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase
US20050244843A1 (en) * 2001-11-16 2005-11-03 Wen-Tien Chen Blood test prototypes and methods for the detection of circulating tumor and endothelial cells
WO2003065019A1 (en) 2002-01-25 2003-08-07 Illumina, Inc. Sensor arrays for detecting analytes in fluids
DE10214395A1 (en) 2002-03-30 2003-10-23 Dmitri Tcherkassov Parallel sequencing of nucleic acid segments, useful for detecting single-nucleotide polymorphisms, by single-base extensions with labeled nucleotide
US7727720B2 (en) * 2002-05-08 2010-06-01 Ravgen, Inc. Methods for detection of genetic disorders
JP2004065736A (en) 2002-08-08 2004-03-04 Nemoto Kyorindo:Kk Liquid medicine injection apparatus
EP1585583B1 (en) * 2002-10-23 2010-04-07 The Trustees of Princeton University Method for continuous particle separation using obstacle arrays asymmetrically aligned to fields
EP1578994A2 (en) 2002-11-11 2005-09-28 Affymetrix, Inc. Methods for identifying dna copy number changes
AU2003291477A1 (en) 2002-11-13 2004-06-03 Molecular Imprints, Inc. A chucking system and method for modulating shapes of substrates
CA2513899C (en) 2003-01-29 2013-03-26 454 Corporation Methods of amplifying and sequencing nucleic acids
US7025935B2 (en) 2003-04-11 2006-04-11 Illumina, Inc. Apparatus and methods for reformatting liquid samples
US8150626B2 (en) 2003-05-15 2012-04-03 Illumina, Inc. Methods and compositions for diagnosing lung cancer with specific DNA methylation patterns
EP1636564A1 (en) 2003-06-13 2006-03-22 The General Hospital Corporation Microfluidic systems for size based removal of red blood cells and platelets from blood
US20050181394A1 (en) 2003-06-20 2005-08-18 Illumina, Inc. Methods and compositions for whole genome amplification and genotyping
EP1689884A4 (en) * 2003-10-08 2007-04-04 Univ Boston METHODS OF PRENATAL DIAGNOSIS OF CHROMOSOMIC ANOMALIES
EP1725572B1 (en) 2003-11-05 2017-05-31 AGCT GmbH Macromolecular nucleotide compounds and methods for using the same
DE10356837A1 (en) 2003-12-05 2005-06-30 Dmitry Cherkasov New conjugates useful for modifying nucleic acid chains comprise nucleotide or nucleoside molecules coupled to a label through water-soluble polymer linkers
US7169560B2 (en) 2003-11-12 2007-01-30 Helicos Biosciences Corporation Short cycle methods for sequencing polynucleotides
US7040959B1 (en) 2004-01-20 2006-05-09 Illumina, Inc. Variable rate dispensing system for abrasive material and method thereof
US20050266432A1 (en) 2004-02-26 2005-12-01 Illumina, Inc. Haplotype markers for diagnosing susceptibility to immunological conditions
DE102004009704A1 (en) 2004-02-27 2005-09-15 Dmitry Cherkasov New conjugates useful for labeling nucleic acids comprise a label coupled to nucleotide or nucleoside molecules through polymer linkers
US20050266433A1 (en) * 2004-03-03 2005-12-01 Ravi Kapur Magnetic device for isolation of cells and biomolecules in a microfluidic environment
US7035740B2 (en) 2004-03-24 2006-04-25 Illumina, Inc. Artificial intelligence and global normalization methods for genotyping
DE102004025694A1 (en) 2004-05-26 2006-02-23 Dmitry Cherkasov Optical fluorescent ultra-high parallel process to analyse nucleic acid chains in which a sample solid is bound with a primer-matrix complex
DE102004025744A1 (en) 2004-05-26 2005-12-29 Dmitry Cherkasov Surface of a solid support, useful for multiple parallel analysis of nucleic acids by optical methods, having low non-specific binding of labeled components
DE102004025695A1 (en) 2004-05-26 2006-02-23 Dmitry Cherkasov Optical fluorescent parallel process to analyse nucleic acid chains in which a sample solid is bound with a primer-matrix complex
DE102004025696A1 (en) 2004-05-26 2006-02-23 Dmitry Cherkasov Ultra-high parallel analysis process to analyse nucleic acid chains in which a sample solid is bound and substrate material
DE102004025745A1 (en) 2004-05-26 2005-12-15 Cherkasov, Dmitry Surface of solid phase, useful for parallel, optical analysis of many nucleic acids, has reduced non-specific binding of labeled components
DE102004025746A1 (en) 2004-05-26 2005-12-15 Dmitry Cherkasov Parallel sequencing of nucleic acids by optical methods, by cyclic primer-matrix extension, using a solid phase with reduced non-specific binding of labeled components
US20060024711A1 (en) 2004-07-02 2006-02-02 Helicos Biosciences Corporation Methods for nucleic acid amplification and sequence determination
US7276720B2 (en) 2004-07-19 2007-10-02 Helicos Biosciences Corporation Apparatus and methods for analyzing samples
US20060012793A1 (en) 2004-07-19 2006-01-19 Helicos Biosciences Corporation Apparatus and methods for analyzing samples
US20060019258A1 (en) 2004-07-20 2006-01-26 Illumina, Inc. Methods and compositions for detection of small interfering RNA and micro-RNA
US20060024678A1 (en) 2004-07-28 2006-02-02 Helicos Biosciences Corporation Use of single-stranded nucleic acid binding proteins in sequencing

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999022868A1 (en) * 1997-10-31 1999-05-14 Bbi Bioseq, Inc. Pressure-enhanced extraction and purification
WO2000040750A1 (en) * 1998-12-30 2000-07-13 Gyros Ab Method for sequencing dna using a microfluidic device
US20030165852A1 (en) * 2000-11-15 2003-09-04 Schueler Paula A. Methods and reagents for identifying rare fetal cells in the maternal circulation
WO2004029221A2 (en) * 2002-09-27 2004-04-08 The General Hospital Corporation Microfluidic device for cell separation and uses thereof

Also Published As

Publication number Publication date
EP2548972A1 (en) 2013-01-23
EP2024512A2 (en) 2009-02-18
EP4170042A1 (en) 2023-04-26
EP2366801A1 (en) 2011-09-21
EP3406736B1 (en) 2022-09-07
WO2007147076A3 (en) 2008-04-03
EP3406736A1 (en) 2018-11-28
HK1162610A1 (en) 2012-08-31
WO2007147076A2 (en) 2007-12-21
EP2366801B1 (en) 2016-10-19

Similar Documents

Publication Publication Date Title
EP2024512A4 (en) METHODS FOR THE DIAGNOSIS OF ABNORMAL F CHARACTERS
FR2935252B1 (en) INSTRUMENT FOR ENDOSCOPE.
EP2005912A4 (en) TREATMENT INSTRUMENT FOR ENDOSCOPE
EP2322109A4 (en) TREATMENT INSTRUMENT FOR ENDOSCOPE
EP2478854A4 (en) TREATMENT INSTRUMENT FOR ENDOSCOPE
EP1931240A4 (en) Diagnosis of optically identifiable ophthalmic conditions
EP2262364A4 (en) OXADIAZOANTHRACENES FOR THE TREATMENT OF DIABETES
GB2473392B (en) Methods of diagnosis
EP1934378A4 (en) DIAGNOSTIC METHODS FOR PANCREATIC CANCER
LT2959894T (en) S1P RECEPTOR MODULATORS FOR THE TREATMENT OF MULTIPLE SCLEROSIS
EP2773779A4 (en) METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF NEUROLOGICAL CONDITIONS
IL197314A0 (en) Performing diagnostic operations upon an asymmetric multiprocessor apparatus
EP2178442A4 (en) CATHETER FOR IMAGING IN-VIVO
EP2427575A4 (en) METHODS AND COMPOSITIONS FOR THE DIAGNOSIS OF THYROID DISORDERS
BRPI1014610A2 (en) Thermowell vibration frequency diagnosis.
GB0807775D0 (en) Methods for model-based diagnosis of gearbox
EP2294213A4 (en) METHODS FOR MODULATING CREB EXPRESSION
FR2930235B1 (en) SUSPENSION MAT FOR TURBOMOTOR.
EP2029771A4 (en) Diagnostic method for myopathy
EP2344667A4 (en) METHODS OF DETERMINING HAPLOTYPE BY HAPLODISSECTION
EP2470074A4 (en) ESTIMATION OF INSTRUMENT FORM
EP2478853A4 (en) TREATMENT INSTRUMENT FOR ENDOSCOPE
EP1943972A4 (en) INSTRUMENT FOR ENDOSCOPIC TREATMENT
FR2935350B1 (en) METHOD FOR REDUCING THE VIBRATION LEVELS OF A TURBOMOTOR PROPELLER
EP2319442A4 (en) TREATMENT INSTRUMENT FOR ENDOSCOPE

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20081212

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

RIC1 Information provided on ipc code assigned before grant

Ipc: C12P 19/34 20060101ALI20090128BHEP

Ipc: G01N 33/48 20060101ALI20090128BHEP

Ipc: C12Q 1/68 20060101AFI20090128BHEP

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: THE GENERAL HOSPITAL CORPORATION

Owner name: CELLECTIVE DX CORPORATION

Owner name: ARTEMIS HEALTH, INC.

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1127892

Country of ref document: HK

A4 Supplementary search report drawn up and despatched

Effective date: 20091109

17Q First examination report despatched

Effective date: 20100702

DAX Request for extension of the european patent (deleted)
RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: THE GENERAL HOSPITAL CORPORATION

Owner name: CELLECTIVE DX CORPORATION

Owner name: VERINATA HEALTH, INC

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: THE GENERAL HOSPITAL CORPORATION

Owner name: CELLECTIVE DX CORPORATION

Owner name: VERINATA HEALTH, INC

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20120905

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1127892

Country of ref document: HK